Compounds > cysteine

cysteine and Parkinsonian Disorders

cysteine has been researched along with Parkinsonian Disorders in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (61.54)29.6817
2010's4 (30.77)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Cho, I; Chun, K; Kong, E1
Bui, LC; Dairou, J; Lamouri, A; Leger, T; Mihoub, M; Richarme, G1
Dairou, J; Richarme, G1
Aoyama, K; Nakaki, T; Watabe, M1
Maldonado, PD; Medina-Campos, ON; Pedraza-Chaverri, J; Rojas, P; Ruiz-Sánchez, E; Serrano-García, N1
Abe, K; Deguchi, K; Deguchi, S; Ikeda, Y; Kametaka, S; Kurata, T; Manabe, Y; Morimoto, N; Ohta, T; Ohta, Y; Sato, S; Takao, Y1
Antonini, A; Benti, R; De Notaris, R; Eidelberg, D; Feigin, A; Fukuda, M; Mentis, MJ; Moeller, JR; Pezzoli, G1
Ruiz-Linares, A1
Gejo, F; Nishizawa, M; Shimohata, T; Takadou, Y; Tanaka, K; Terajima, K; Tsukada, H1
Glaser, A; Herva, R; Ingelsson, M; Jönhagen, ME; Kalimo, H; Lannfelt, L; Skoglund, L; Viitanen, M1
Benecke, R; Berg, D; Bonifati, V; Brown, L; Cras, P; De Deyn, PP; Engelborghs, S; Farrer, MJ; Foroud, T; Gaig, C; Gasser, T; Gibson, JM; Goldwurm, S; Guidi, M; Hagenah, J; Haugarvoll, K; Kachergus, JM; Klein, C; Nichols, WC; Nuytemans, K; Pals, P; Pickut, B; Rademakers, R; Riboldazzi, G; Ross, OA; Samii, A; Tan, EK; Theuns, J; Tolosa, E; Uitti, RJ; Van Broeckhoven, C; Walter, U; Wszolek, ZK; Zabetian, CP1
Arias, W; Bedoya, G; Buriticá, O; Carvajal-Carmona, LG; García, F; Lopera, F; Moreno, S; Pineda, D; Pineda-Trujillo, N; Ruiz-Linares, A; Toro, M; Uribe, C1
Kawai, M; Ogawa, M; Oya, Y; Shigeto, H; Yoshioka, M1

Reviews

1 review(s) available for cysteine and Parkinsonian Disorders

ArticleYear
Regulation of neuronal glutathione synthesis.
    Journal of pharmacological sciences, 2008, Volume: 108, Issue:3

    Topics: Animals; Antioxidants; Cysteine; Disease Models, Animal; Excitatory Amino Acid Transporter 3; Glutamate Plasma Membrane Transport Proteins; Glutathione; Humans; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders

2008

Other Studies

12 other study(ies) available for cysteine and Parkinsonian Disorders

ArticleYear
Comparison of perfusion 18F-FP-CIT PET and 99mTc-ECD SPECT in parkinsonian disorders.
    Medicine, 2021, Aug-27, Volume: 100, Issue:34

    Topics: Aged; Brain; Cysteine; Dopamine Plasma Membrane Transport Proteins; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Organotechnetium Compounds; Parkinsonian Disorders; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tropanes

2021
Parkinsonism-associated protein DJ-1/Park7 is a major protein deglycase that repairs methylglyoxal- and glyoxal-glycated cysteine, arginine, and lysine residues.
    The Journal of biological chemistry, 2015, Jan-16, Volume: 290, Issue:3

    Topics: Acetylcysteine; Albumins; Apoptosis; Arginine; Aspartate Aminotransferases; Catalysis; Cell Survival; Cysteine; Escherichia coli; Fructose-Bisphosphate Aldolase; Glucose; Glycolates; Glyoxal; Humans; Intracellular Signaling Peptides and Proteins; Lactates; Lysine; Mass Spectrometry; Oncogene Proteins; Oxidative Stress; Parkinsonian Disorders; Protein Deglycase DJ-1; Pyruvaldehyde

2015
Parkinsonism-associated protein DJ-1 is a bona fide deglycase.
    Biochemical and biophysical research communications, 2017, 01-29, Volume: 483, Issue:1

    Topics: Acetylcysteine; Artifacts; Culture Media; Cysteine; Escherichia coli; Glucose; Glycation End Products, Advanced; Glycosylation; Glyoxal; Humans; Intracellular Signaling Peptides and Proteins; Mutation; Oncogene Proteins; Parkinsonian Disorders; Protein Deglycase DJ-1; Pyruvaldehyde

2017
S-Allylcysteine, a garlic compound, protects against oxidative stress in 1-methyl-4-phenylpyridinium-induced parkinsonism in mice.
    The Journal of nutritional biochemistry, 2011, Volume: 22, Issue:10

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; Cysteine; Garlic; Glutathione Reductase; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Superoxide Dismutase

2011
PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
    Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:22

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Basal Ganglia; Cerebral Cortex; Cerebrovascular Circulation; Cysteine; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Organotechnetium Compounds; Parkinson Disease; Parkinsonian Disorders; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon

2011
Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:6

    Topics: Aged; Brain; Cysteine; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Nerve Net; Organotechnetium Compounds; Parkinson Disease; Parkinsonian Disorders; Regional Blood Flow; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon

2002
Juvenile Parkinson disease and the C212Y mutation of parkin.
    Archives of neurology, 2004, Volume: 61, Issue:3

    Topics: Colombia; Cysteine; Humans; Mutation; Parkinsonian Disorders; Spain; Tyrosine; Ubiquitin-Protein Ligases

2004
[A patient with HIV encephalopathy presenting with parkinsonism during HAART therapy].
    No to shinkei = Brain and nerve, 2006, Volume: 58, Issue:6

    Topics: Adult; AIDS Dementia Complex; Antiretroviral Therapy, Highly Active; Brain; CD4 Lymphocyte Count; Cysteine; Humans; Lower Extremity; Magnetic Resonance Imaging; Male; Organotechnetium Compounds; Parkinsonian Disorders; Tomography, Emission-Computed, Single-Photon

2006
The tau S305S mutation causes frontotemporal dementia with parkinsonism.
    European journal of neurology, 2008, Volume: 15, Issue:2

    Topics: Adult; Amino Acid Substitution; Behavior; Brain; Cognition Disorders; Cysteine; Dementia; Humans; Male; Mutation; Parkinsonian Disorders; Pedigree; Personality; Phenotype; Protein Isoforms; tau Proteins; Threonine

2008
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease.
    Neurology, 2008, Apr-15, Volume: 70, Issue:16 Pt 2

    Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Arginine; Cysteine; DNA Mutational Analysis; Female; Glycine; Haplotypes; Humans; Internationality; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Protein Serine-Threonine Kinases; Serine

2008
A novel Cys212Tyr founder mutation in parkin and allelic heterogeneity of juvenile Parkinsonism in a population from North West Colombia.
    Neuroscience letters, 2001, Feb-02, Volume: 298, Issue:2

    Topics: Adolescent; Adult; Age of Onset; Alleles; Colombia; Cysteine; Family Health; Female; Founder Effect; Genetic Heterogeneity; Humans; Ligases; Male; Parkinsonian Disorders; Pedigree; Point Mutation; Tyrosine; Ubiquitin-Protein Ligases

2001
[Juvenile parkinsonism with symmetrical hypoperfusion in the cerebellum--a case report].
    Rinsho shinkeigaku = Clinical neurology, 2000, Volume: 40, Issue:10

    Topics: Adult; Cerebellum; Cerebrovascular Circulation; Cysteine; Female; Humans; Male; Middle Aged; Musculoskeletal Diseases; Organotechnetium Compounds; Parkinsonian Disorders; Posture; Radiopharmaceuticals; Reflex; Tomography, Emission-Computed, Single-Photon

2000